The WHO guideline also emphasized that obesity is a chronic, relapsing disease requiring long-term treatment, not a short-term intervention
Abstract Glucagon-like peptide-1 (GLP-1) is a 30-amino acid hormone secreted by L cells in the distal ileum, colon, and pancreatic cells, which participates in blood sugar regulation by promoting insulin release, reducing glucagon levels, delaying gastric emptying, increasing satiety, and reducing appetite
Joint health: synovial inflammation degrades cartilage
What GLP-1 Actually Means If you are going to consider these medications, it helps to understand what they actually do in plain terms rather than pharmaceutical jargon
GLP-1s and cancer: promising but no clinical trial evidence Obesity is a risk factor for at least 13 cancers, so reducing weight using GLP-1 drugs can also be expected to limit cancer risk